Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Myomo Inc (MYO)

Myomo Inc (MYO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,147
  • Shares Outstanding, K 5,730
  • Annual Sales, $ 7,580 K
  • Annual Income, $ -11,560 K
  • 60-Month Beta 1.47
  • Price/Sales 8.61
  • Price/Cash Flow N/A
  • Price/Book 4.82
Trade MYO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.47
  • Number of Estimates 3
  • High Estimate -0.41
  • Low Estimate -0.56
  • Prior Year -0.70
  • Growth Rate Est. (year over year) +32.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.57 +32.67%
on 08/17/21
12.00 -5.25%
on 09/07/21
+2.26 (+24.81%)
since 08/16/21
3-Month
7.19 +58.14%
on 07/30/21
12.00 -5.25%
on 09/07/21
+0.01 (+0.09%)
since 06/16/21
52-Week
4.12 +175.97%
on 09/24/20
18.88 -39.78%
on 02/16/21
+6.38 (+127.86%)
since 09/16/20

Most Recent Stories

More News
Exoskeleton Market Size 2021 Explosive Factors of Revenue By Progression Status, Emerging Demands, Recent Trends, Business Opportunity, Share and Forecast To 2027

The Exoskeleton Market is segmented on the lines of its end-user, technology, Stationary Technology and regional. Based on end-user it covers HealthCare, Military and Industrial. Basis of Stationary Technology...

MYO : 11.37 (-0.18%)
EKSO : 4.33 (+5.10%)
RWLK : 1.2500 (-1.57%)
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

MYO : 11.37 (-0.18%)
Myomo to Report Second Quarter 2021 Financial Results on August 9, 2021

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 11.37 (-0.18%)
Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MYO : 11.37 (-0.18%)
Myomo Receives Accreditation from HQAA

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 11.37 (-0.18%)
Myomo, Inc. Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 11.37 (-0.18%)
Myomo, Inc. Stock Added to Russell Microcap(R) Index

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 11.37 (-0.18%)
Sidoti Summer Virtual Small-Cap Conference

GRYCF : 0.3283 (+0.06%)
AGI.TO : 9.44 (-4.65%)
AINC : 13.81 (-5.48%)
ALCO : 35.61 (-0.64%)
ATEN : 14.60 (-1.08%)
AUDC : 32.75 (+1.93%)
AX : 45.22 (-1.18%)
BBSI : 76.07 (-0.04%)
BHR : 5.15 (+1.58%)
BKH : 66.61 (-1.60%)
BOOM : 39.97 (-1.11%)
BRC : 49.74 (-0.68%)
BZH : 18.12 (+1.51%)
CGRN : 4.77 (+6.00%)
CMCO : 43.65 (-0.80%)
CMTL : 25.63 (+0.75%)
CNXN : 45.14 (-0.38%)
CRAI : 92.15 (+0.09%)
CSV : 46.00 (+1.61%)
CULP : 12.64 (-0.86%)
DLX : 35.95 (-0.33%)
EGLE : 52.61 (+0.59%)
FORR : 47.30 (+1.65%)
GNK : 21.35 (-0.05%)
HAYN : 36.88 (-2.46%)
HOFT : 27.43 (-0.36%)
HRTG : 5.54 (-8.58%)
HSII : 43.56 (-1.29%)
HSON : 16.00 (-1.23%)
HVT : 33.82 (-1.17%)
INS : 38.20 (+4.57%)
IRDM : 44.40 (-0.76%)
JOUT : 105.95 (-1.52%)
KE : 25.90 (+1.17%)
KELYA : 20.03 (-1.67%)
KIRK : 19.11 (-0.78%)
LAKE : 21.20 (-1.07%)
LOV : 3.49 (+1.45%)
MDCA : 5.42 (-3.39%)
MG : 9.52 (+0.32%)
MTRN : 70.19 (-2.82%)
MTX : 72.06 (-2.03%)
MYO : 11.37 (-0.18%)
MYRG : 104.05 (-1.44%)
NSIT : 92.07 (-1.33%)
OR.TO : 15.17 (-1.75%)
OSPN : 19.64 (-3.91%)
PCYO : 13.09 (-2.09%)
POWL : 23.56 (-4.31%)
PRIM : 25.90 (-1.03%)
PYR.TO : 5.46 (-1.80%)
QADA : 87.30 (-0.06%)
QTRH.TO : 2.61 (unch)
RGP : 15.00 (-1.96%)
SAFE : 79.86 (-1.13%)
SCVL : 34.82 (-0.09%)
SIFY : 3.31 (-1.49%)
SOL : 6.88 (-4.18%)
SREV : 1.3700 (unch)
SRGA : 1.4500 (+3.57%)
SWM : 34.19 (-1.78%)
TBI : 27.94 (-0.32%)
TNC : 73.49 (-2.07%)
TWI : 7.25 (+0.69%)
VERI : 21.63 (+4.44%)
VNRX : 3.17 (-0.63%)
Myomo to Present at Sidoti Virtual Investor Conference on June 23, 2021

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 11.37 (-0.18%)
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Myomo, Inc. for Potential Breach of Fiduciary Duty Claims

NEW YORK, NY / ACCESSWIRE / June 15, 2021 / Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Myomo, Inc. .

MYO : 11.37 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

3rd Resistance Point 12.45
2nd Resistance Point 12.06
1st Resistance Point 11.71
Last Price 11.37
1st Support Level 10.97
2nd Support Level 10.58
3rd Support Level 10.23

See More

52-Week High 18.88
Fibonacci 61.8% 13.24
Fibonacci 50% 11.50
Last Price 11.37
Fibonacci 38.2% 9.76
52-Week Low 4.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar